Efficacy of pirtobrutinib in covalent BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Additional patients and extended follow-up from the phase 1/2 BRUIN study Meeting Abstract
| Authors: | Mato, A. R.; Woyach, J. A.; Brown, J. R.; Ghia, P.; Patel, K.; Eyre, T. A.; Munir, T.; Lech-Maranda, E.; Lamanna, N.; Tam, C. S.; Seymour, J. F.; Shah, N. N.; Coombs, C. C.; Ujjani, C. S.; Patel, M. R.; Fakhri, B.; Cheah, C. Y.; Alencar, A. J.; Cohen, J. B.; Gerson, J. N.; Flinn, I. W.; Ma, S.; Jagadeesh, D.; Rhodes, J. M.; Hernandez-Ilizaliturri, F.; Zinzani, P. L.; Balbas, M.; Nair, B.; Abada, P. B.; Wang, C.; Wang, D.; Tsai, D. E.; Wierda, W. G.; Jurczak, W. |
| Abstract Title: | Efficacy of pirtobrutinib in covalent BTK-inhibitor pre-treated relapsed/refractory CLL/SLL: Additional patients and extended follow-up from the phase 1/2 BRUIN study |
| Meeting Title: | 64th Annual Meeting of the American Society of Hematology (ASH) |
| Journal Title: | Blood |
| Volume: | 140 |
| Issue: | Suppl. 1 |
| Meeting Dates: | 2022 Dec 10-13 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0006-4971 |
| Publisher: | American Society of Hematology |
| Date Published: | 2022-11-15 |
| Start Page: | 2316 |
| End Page: | 2320 |
| Language: | English |
| ACCESSION: | WOS:000893223202136 |
| DOI: | 10.1182/blood-2022-159497 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract -- Source: Wos |
